ReviewBlood cancer discovery2024

T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment.

Niels W C J van de Donk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.